Erin Estey Hertzog is a Partner with Manatt Health who brings a proactive approach to client service to help advance clients’ business interests across some of the most urgent and impactful health care policies and innovations.
Erin helps clients navigate complex Medicare and Medicaid coverage and payment issues for novel technologies, including by addressing legal and regulatory matters before the Department of Health and Human Services. Erin is also a leading authority on the 340B Drug Pricing Program and, since its enactment in 2022, has assisted clients with all elements of the drug price provisions of the Inflation Reduction Act. Erin brings particular legal and policy knowledge specific to kidney disease, vaccines, rare diseases, and cell and gene therapy.
Erin also works with clients to provide guidance surrounding delivery system reform and value-based payment models, As the former lead attorney for the Center for Medicare and Medicaid Innovation (CMMI), Erin helped inform health care transformation nationwide, advising on dozens of CMMI’s innovative payment and service-delivery models. She has since leveraged this experience to advise clients on the development and implementation of innovative payment arrangements, including in the context of CMMI’s payment models.